Entering text into the input field will update the search result below

ResMed EPS in-line, misses on revenue

Apr. 23, 2015 4:20 PM ETResMed Inc. (RMD) StockBy: Mohit Manghnani, SA News Editor
  • ResMed (NYSE:RMD): FQ3 EPS of $0.65 in-line.
  • Revenue of $422.5M (+6.2% Y/Y) misses by $2.29M.
  • Shares -0.9%.
  • Press Release

Recommended For You

More Trending News

About RMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RMD--
ResMed Inc.